Endocrinology, Vol 136, 3839-3848, Copyright © 1995 by Endocrine Society

ARTICLES

Recombinant thyrotropin containing a beta-subunit chimera with the human chorionic gonadotropin-beta carboxy-terminus is biologically active, with a prolonged plasma half-life: role of carbohydrate in bioactivity and metabolic clearance

L Joshi, Y Murata, FE Wondisford, MW Szkudlinski, R Desai and BD Weintraub
Molecular and Cellular Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

Recombinant TSH is now successfully being used in clinical studies of thyroid cancer. Because of its therapeutic potential, we have constructed a longer acting analog of TSH by fusing the carboxy- terminal extension peptide (CTEP) of hCG beta onto TSH beta. When coexpressed either with alpha-subunit complementary DNA or alpha minigene in African green monkey (COS-7) and human embryonic kidney (293) cells, the chimera was fully bioactive in vitro and exhibited enhanced in vivo potency associated with a prolonged plasma half-life. The addition of 25 amino acids with 4 O-linked oligosaccharide chains did not affect the assembly and secretion of chimeric TSH. Wild-type (WT) and chimeric TSH secreted by COS-7 and 293 cells displayed wide differences in their plasma half-lives, presumably due to the presence of terminal sialic acid and SO4 on their oligosaccharide chains, respectively. Chimeric and WT TSH secreted by both cell lines demonstrated similar bioactivity in cAMP production, with some differences in [3H]thymidine incorporation. Chimeric TSH appears to be more effective in COS-7 cells than in 293 cells, as judged by growth assay. COS-7-produced chimeric TSH showed the maximum increase in half- life, indicating the importance of sialic acid in prolonging half-life and in vivo potency. Sulfation of both subunits, predominantly beta and to a lesser extent alpha, appears to be responsible at least in part for the increased metabolic clearance of WT and chimeric TSH secreted by 293 cells. Apart from its therapeutic potential, chimeric TSH produced in various cell lines can be used as a tool to delineate the roles of sulfate and sialic acid in the in vivo clearance and, thereby, the in vivo bioactivity.

This article has been cited by other articles:

				E. P Lemke, B. M Adams, A. Jablonka-Shariff, I. Boime, and T. E Adams Single-chain human gonadotropin analogs induce follicle development in sheep J. Endocrinol., March 1, 2008; 196(3): 593 - 600. [Abstract] [Full Text] [PDF]

				F. Fares, S. Ganem, T. Hajouj, and E. Agai Development of a Long-Acting Erythropoietin by Fusing the Carboxyl-Terminal Peptide of Human Chorionic Gonadotropin {beta}-Subunit to the Coding Sequence of Human Erythropoietin Endocrinology, October 1, 2007; 148(10): 5081 - 5087. [Abstract] [Full Text] [PDF]

				P. R. Manna, L. Joshi, V. N. Reinhold, M. L. Aubert, N. Suganuma, K. Pettersson, and I. T. Huhtaniemi Synthesis, purification and structural and functional characterization of recombinant form of a common genetic variant of human luteinizing hormone Hum. Mol. Genet., February 1, 2002; 11(3): 301 - 315. [Abstract] [Full Text] [PDF]

				J. Bielicki, A. C. Crawley, R. C. A. Davey, J. C. Varnai, and J. J. Hopwood Advantages of Using Same Species Enzyme for Replacement Therapy in a Feline Model of Mucopolysaccharidosis Type VI J. Biol. Chem., December 17, 1999; 274(51): 36335 - 36343. [Abstract] [Full Text] [PDF]

				F. A. Fares, S. Yamabe, D. Ben-Menahem, M. Pixley, A. J. W. Hsueh, and I. Boime Conversion of Thyrotropin Heterodimer to a Biologically Active Single-Chain Endocrinology, May 1, 1998; 139(5): 2459 - 2464. [Abstract] [Full Text] [PDF]

				P. Cousin, H. Déchaud, C. Grenot, H. Lejeune, M. Pugeat with the technical assistance of, C. Baret, and C. Brébant Human Variant Sex Hormone-Binding Globulin (SHBG) with an Additional Carbohydrate Chain Has a Reduced Clearance Rate in Rabbit J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 235 - 240. [Abstract] [Full Text]

				M. Grossmann, R. Wong, M. W. Szkudlinski, and B. D. Weintraub Human Thyroid-stimulating Hormone (hTSH) Subunit Gene Fusion Produces hTSH with Increased Stability and Serum Half-life and Compensates for Mutagenesis-induced Defects in Subunit Association J. Biol. Chem., August 22, 1997; 272(34): 21312 - 21316. [Abstract] [Full Text] [PDF]

				M. Grossmann, B. D. Weintraub, and M. W. Szkudlinski Novel Insights into the Molecular Mechanisms of Human Thyrotropin Action: Structural, Physiological, and Therapeutic Implications for the Glycoprotein Hormone Family Endocr. Rev., August 1, 1997; 18(4): 476 - 501. [Abstract] [Full Text] [PDF]

				M. Grossmann, R. Wong, N. G. Teh, J. E. Tropea, J. East-Palmer, B. D. Weintraub, and M. W. Szkudlinski Expression of Biologically Active Human Thyrotropin (hTSH) in a Baculovirus System: Effect of Insect Cell Glycosylation on hTSH Activity in Vitro and in Vivo Endocrinology, January 1, 1997; 138(1): 92 - 100. [Abstract] [Full Text] [PDF]

				M. Grossmann, M. W. Szkudlinski, J. E. Tropea, L. A. Bishop, N. R. Thotakura, P. R. Schofield, and B. D. Weintraub Expression of Human Thyrotropin in Cell Lines with Different Glycosylation Patterns Combined with Mutagenesis of Specific Glycosylation Sites J. Biol. Chem., December 8, 1995; 270(49): 29378 - 29385. [Abstract] [Full Text] [PDF]

				H. Leitolf, K. P. T. Tong, M. Grossmann, B. D. Weintraub, and M. W. Szkudlinski Bioengineering of Human Thyrotropin Superactive Analogs by Site-directed "Lysine-scanning" Mutagenesis. COOPERATIVE EFFECTS BETWEEN PERIPHERAL LOOPS J. Biol. Chem., August 25, 2000; 275(35): 27457 - 27465. [Abstract] [Full Text] [PDF]

				F. A. Fares, F. Levi, A. Z. Reznick, and Z. Kraiem Engineering a Potential Antagonist of Human Thyrotropin and Thyroid-stimulating Antibody J. Biol. Chem., February 9, 2001; 276(7): 4543 - 4548. [Abstract] [Full Text] [PDF]